Variations in risk-adjusted outcomes following 4318 laparoscopic liver resections.
heterogeneity
laparoscopic liver resection
mortality, morbidity
risk-adjustment
Journal
Journal of hepato-biliary-pancreatic sciences
ISSN: 1868-6982
Titre abrégé: J Hepatobiliary Pancreat Sci
Pays: Japan
ID NLM: 101528587
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
revised:
23
01
2022
received:
19
10
2021
accepted:
26
01
2022
pubmed:
20
3
2022
medline:
3
6
2022
entrez:
19
3
2022
Statut:
ppublish
Résumé
Quality measures in surgery are important to establish appropriate levels of care and to develop improvement strategies. The purpose of this study was to provide risk-adjusted outcome measures after laparoscopic liver resection (LLR). Data from a prospective, multicenter database involving 4318 patients submitted to LLRs in 41 hospitals from an intention-to-treat approach (2014-2020) were used to analyze heterogeneity (I Involved hospitals operated on very different patients: the largest heterogeneity was observed for operating in the presence of previous abdominal surgery (I A benchmark for LLRs including all eligible patients was provided, suggesting that surgeons can act accordingly in the interest of the patient, modifying their approach in relation to different indications and different experience, but finally providing the same quality of care.
Sections du résumé
BACKGROUND/PURPOSE
OBJECTIVE
Quality measures in surgery are important to establish appropriate levels of care and to develop improvement strategies. The purpose of this study was to provide risk-adjusted outcome measures after laparoscopic liver resection (LLR).
METHODS
METHODS
Data from a prospective, multicenter database involving 4318 patients submitted to LLRs in 41 hospitals from an intention-to-treat approach (2014-2020) were used to analyze heterogeneity (I
RESULTS
RESULTS
Involved hospitals operated on very different patients: the largest heterogeneity was observed for operating in the presence of previous abdominal surgery (I
CONCLUSIONS
CONCLUSIONS
A benchmark for LLRs including all eligible patients was provided, suggesting that surgeons can act accordingly in the interest of the patient, modifying their approach in relation to different indications and different experience, but finally providing the same quality of care.
Identifiants
pubmed: 35305075
doi: 10.1002/jhbp.1141
pmc: PMC9324820
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
521-530Investigateurs
Giuseppe Maria Ettorre
(GM)
Fabrizio di Benedetto
(F)
Raffaele Dalla Valle
(RD)
Salvatore Gruttadauria
(S)
Elio Jovine
(E)
Ugo Boggi
(U)
Leonardo Vincenti
(L)
Roberto Santambrogio
(R)
Antonio Giuliani
(A)
Guido Torzilli
(G)
Giuliano Zimmiti
(G)
Alberto Brolese
(A)
Andrea Belli
(A)
Matteo Ravaioli
(M)
Antonio Frena
(A)
Giorgio Ettore Rossi
(GE)
Gian Luca Grazi
(GL)
Fausto Zamboni
(F)
Stefano Berti
(S)
Fulvio Calise
(F)
Marco Massani
(M)
Luca Morelli
(L)
Marco Filauro
(M)
Giuseppe Tisone
(G)
Andrea Coratti
(A)
Giuseppe Navarra
(G)
Raffaele Romito
(R)
Graziano Ceccarelli
(G)
Giulio Belli
(G)
Guido Griseri
(G)
Adelmo Antonucci
(A)
Pietro Mezzatesta
(P)
Luigi Veneroni
(L)
Marcello Schiavo
(M)
Michele Colledan
(M)
Amilcare Parisi
(A)
Silvio Guerriero
(S)
Marco Spada
(M)
Giacomo Batignani
(G)
Giovanni Sgroi
(G)
Piero Floridi
(P)
Luigi Boni
(L)
Pietro Maida
(P)
Dario Ribero
(D)
Giuliano La Barba
(G)
Informations de copyright
© 2022 The Authors. Journal of Hepato-Biliary-Pancreatic Sciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Références
Ann Surg. 2018 Dec;268(6):1051-1057
pubmed: 28582270
Ann Surg. 2022 Jan 1;275(1):166-174
pubmed: 32224747
J Hepatobiliary Pancreat Sci. 2022 May;29(5):521-530
pubmed: 35305075
J Laparoendosc Adv Surg Tech A. 2018 Jul;28(7):785-791
pubmed: 29589990
J Hepatobiliary Pancreat Sci. 2014 Oct;21(10):745-53
pubmed: 25242563
Updates Surg. 2017 Sep;69(3):271-283
pubmed: 28861759
Ann Surg. 2021 Dec 1;274(6):1043-1050
pubmed: 32209896
Br J Surg. 2016 Oct;103(11):1405-7
pubmed: 27464356
Ann Surg. 2016 Sep;264(3):492-500
pubmed: 27433909
Br J Surg. 2020 Jun;107(7):845-853
pubmed: 31925777
Ann Surg. 2015 Apr;261(4):619-29
pubmed: 25742461
Ann Surg. 2018 Jan;267(1):13-17
pubmed: 28187043
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Ann Surg. 2016 Nov;264(5):778-786
pubmed: 27429038
Surg Endosc. 2020 May;34(5):2056-2066
pubmed: 31338665
HPB (Oxford). 2019 Sep;21(9):1139-1149
pubmed: 30718185
HPB (Oxford). 2019 Dec;21(12):1734-1743
pubmed: 31235430
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Nature. 2019 Mar;567(7748):305-307
pubmed: 30894741
Int J Surg. 2020 Dec;84:78-84
pubmed: 33091619
Hepatobiliary Surg Nutr. 2016 Aug;5(4):281-9
pubmed: 27500140
J Hepatol. 2020 Nov;73(5):1100-1108
pubmed: 32407812
J Am Coll Surg. 2013 Aug;217(2):336-46.e1
pubmed: 23628227
Ann Surg. 2009 Nov;250(5):831-41
pubmed: 19801936
Ann Surg. 2018 Jul;268(1):11-18
pubmed: 29064908
JAMA. 1997 Nov 19;278(19):1600-7
pubmed: 9370507
J Hepatol. 2021 Apr;74(4):985-986
pubmed: 33340571
HPB (Oxford). 2021 May;23(5):770-776
pubmed: 33023824
HPB (Oxford). 2014 Jan;16(1):75-82
pubmed: 23490275
Br J Surg. 2019 Oct;106(11):1512-1522
pubmed: 31441944